The US National Institutes of Health (NIH) have extended their agreement for the operation of the Molecular Libraries Small Molecule Repository (MLSMR) through December 2012.
According to the terms of this agreement, Biofocus will be eligible to receive up to USD8.6m (GBP5.7m) over the course of the two-year extension.
Biofocus runs a compound management facility for a number of industrial and US government customers out of its Compound Focus subsidiary in South San Francisco.
This facility acquires and stores compounds under the NIH contract and distributes them for high-throughput biological screening throughout the NIH's academic network in the US.
